BioSenic S.A. (EBR:BIOS)
Belgium
· Delayed Price · Currency is EUR 0.0024
-0.0001 (-4.00%)
Mar 6, 2026, 12:33 PM CET
BioSenic Company Description
BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases.
In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium.
BioSenic S.A.
| Country | Belgium |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Jean-Luc Vandebroek |
Contact Details
Address: Avenue Léon champagne, 3 Saintes, 1480 Belgium | |
| Phone | 32 478 27 68 42 |
| Website | biosenic.com |
Stock Details
| Ticker Symbol | BIOS |
| Exchange | Euronext Brussels |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | BE0974280126 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jean-Luc Vandebroek | Interim Chief Executive Officer and Director |